B

Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613

Watchlist Manager
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Watchlist
Price: 8.05 HKD 0.63%
Market Cap: 6.7B HKD
Have any thoughts about
Beijing Tong Ren Tang Chinese Medicine Co Ltd?
Write Note

Beijing Tong Ren Tang Chinese Medicine Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Beijing Tong Ren Tang Chinese Medicine Co Ltd
Revenue Peer Comparison

Comparables:
G
512
U
3933
1177
C
3320
H
13

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
B
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Revenue
HK$1.4B
CAGR 3-Years
-2%
CAGR 5-Years
-10%
CAGR 10-Years
7%
G
Grand Pharmaceutical Group Ltd
HKEX:512
Revenue
HK$10.6B
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
14%
U
United Laboratories International Holdings Ltd
HKEX:3933
Revenue
ÂĄ14B
CAGR 3-Years
15%
CAGR 5-Years
12%
CAGR 10-Years
9%
Sino Biopharmaceutical Ltd
HKEX:1177
Revenue
ÂĄ26.8B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
12%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Revenue
HK$373.3B
CAGR 3-Years
18%
CAGR 5-Years
14%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Revenue
$610.8m
CAGR 3-Years
30%
CAGR 5-Years
23%
CAGR 10-Years
26%

See Also

What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Revenue?
Revenue
1.4B HKD

Based on the financial report for Jun 30, 2024, Beijing Tong Ren Tang Chinese Medicine Co Ltd's Revenue amounts to 1.4B HKD.

What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
7%

Over the last year, the Revenue growth was -28%. The average annual Revenue growth rates for Beijing Tong Ren Tang Chinese Medicine Co Ltd have been -2% over the past three years , -10% over the past five years , and 7% over the past ten years .

Back to Top